Erstellt von fchar99
Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Corp.
WKN: 936853 / Symbol: EW / Name: Edwards Lifesciences / Aktie / Ausrüstung & Versorgung / Large Cap /
73,15 €
-0,94 %
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Wells Fargo & Company from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Barclays PLC from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $90.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Citigroup Inc. from $83.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Royal Bank of Canada from $85.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $75.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Barclays PLC from $85.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $81.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Citigroup Inc. from $81.00 to $83.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $60.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $85.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Barclays PLC from $88.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $73.00.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Piper Sandler from $80.00 to $83.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Citigroup Inc. from $84.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Mizuho from $85.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Corporation (NYSE: EW) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $85.00 to $94.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Neueste Beiträge
TD_Cowen in Servicenow Inc. diskutieren, ServiceNow Inc.